
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class
Francesca D'Amico, Rishov Mukhopadhyay, Huib Ovaa, et al.
ChemBioChem (2021) Vol. 22, Iss. 12, pp. 2011-2031
Open Access | Times Cited: 33
Francesca D'Amico, Rishov Mukhopadhyay, Huib Ovaa, et al.
ChemBioChem (2021) Vol. 22, Iss. 12, pp. 2011-2031
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
TRIM family contribute to tumorigenesis, cancer development, and drug resistance
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 86
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 86
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
Panrui Lu, Y. Cheng, Lei Xue, et al.
Cell (2024)
Closed Access | Times Cited: 14
Panrui Lu, Y. Cheng, Lei Xue, et al.
Cell (2024)
Closed Access | Times Cited: 14
The translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 40
Zhao Guo, Chuan Liu, Xin Wen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107881-107881
Closed Access | Times Cited: 40
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase
Klemens Hoegenauer, Shaojian An, Jake Axford, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1631-1639
Closed Access | Times Cited: 16
Klemens Hoegenauer, Shaojian An, Jake Axford, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1631-1639
Closed Access | Times Cited: 16
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases
Adam Hage, Marianne Janes, Sonja M. Best
Viruses (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access
Adam Hage, Marianne Janes, Sonja M. Best
Viruses (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access
TRIM32: A Multifunctional Protein Involved in Muscle Homeostasis, Glucose Metabolism, and Tumorigenesis
Simranjot Bawa, Rosanna Piccirillo, Erika R. Geisbrecht
Biomolecules (2021) Vol. 11, Iss. 3, pp. 408-408
Open Access | Times Cited: 25
Simranjot Bawa, Rosanna Piccirillo, Erika R. Geisbrecht
Biomolecules (2021) Vol. 11, Iss. 3, pp. 408-408
Open Access | Times Cited: 25
Ubiquitination, Biotech Startups, and the Future of TRIM Family Proteins: A TRIM-Endous Opportunity
Utsa Bhaduri, Giuseppe Merla
Cells (2021) Vol. 10, Iss. 5, pp. 1015-1015
Open Access | Times Cited: 17
Utsa Bhaduri, Giuseppe Merla
Cells (2021) Vol. 10, Iss. 5, pp. 1015-1015
Open Access | Times Cited: 17
Mechanism of autophagy induced by activation of the AMPK/ERK/mTOR signaling pathway after TRIM22-mediated DENV-2 infection of HUVECs
Ning Wu, Xiaoqin Gou, Pan Hu, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Ning Wu, Xiaoqin Gou, Pan Hu, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis
Jessica Elisabetta Esposito, Vincenzo De Iuliis, Francesco Avolio, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2309-2309
Open Access | Times Cited: 11
Jessica Elisabetta Esposito, Vincenzo De Iuliis, Francesco Avolio, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2309-2309
Open Access | Times Cited: 11
Activation of the lysosomal damage response and selective autophagy: the coordinated actions of galectins, TRIM proteins, and CGAS-STING1 in providing immunity against Mycobacterium tuberculosis
Asrar Ahmad Malik, Mohd Shariq, Javaid Ahmad Sheikh, et al.
Critical Reviews in Microbiology (2024), pp. 1-20
Closed Access | Times Cited: 2
Asrar Ahmad Malik, Mohd Shariq, Javaid Ahmad Sheikh, et al.
Critical Reviews in Microbiology (2024), pp. 1-20
Closed Access | Times Cited: 2
It’s a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease
Jane Fraser, Katrin Rittinger
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
Jane Fraser, Katrin Rittinger
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
BRD9 Bifunctional Degraders for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1879-1880
Open Access | Times Cited: 13
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 12, pp. 1879-1880
Open Access | Times Cited: 13
Clover: An unbiased method for prioritizing differentially expressed genes using a data‐driven approach
Gina Miku Oba, Ryuichiro Nakato
Genes to Cells (2024) Vol. 29, Iss. 6, pp. 456-470
Open Access | Times Cited: 1
Gina Miku Oba, Ryuichiro Nakato
Genes to Cells (2024) Vol. 29, Iss. 6, pp. 456-470
Open Access | Times Cited: 1
A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7
Christian J. Muñoz Sosa, Christopher Lenz, Anton Hamann, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1638-1647
Closed Access | Times Cited: 1
Christian J. Muñoz Sosa, Christopher Lenz, Anton Hamann, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 7, pp. 1638-1647
Closed Access | Times Cited: 1
Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains
Angelina R. Sekirnik, Jessica K. Reynolds, Larissa See, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 10, pp. 2753-2768
Open Access | Times Cited: 7
Angelina R. Sekirnik, Jessica K. Reynolds, Larissa See, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 10, pp. 2753-2768
Open Access | Times Cited: 7
Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma
Wei Hu, Dongsheng Liu, Renjie Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Wei Hu, Dongsheng Liu, Renjie Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
A. Chaikuad, Rezart Zhubi, Claudia Tredup, et al.
IUCrJ (2022) Vol. 9, Iss. 6, pp. 720-727
Open Access | Times Cited: 6
A. Chaikuad, Rezart Zhubi, Claudia Tredup, et al.
IUCrJ (2022) Vol. 9, Iss. 6, pp. 720-727
Open Access | Times Cited: 6
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design
Tommaso Palomba, Giusy Tassone, Carmine Vacca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14218-14218
Open Access | Times Cited: 6
Tommaso Palomba, Giusy Tassone, Carmine Vacca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14218-14218
Open Access | Times Cited: 6
Small molecules targeting ubiquitination to control inflammatory diseases
Zheng-Qing Li, Xiuping Chen, Ying Wang
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2414-2422
Closed Access | Times Cited: 8
Zheng-Qing Li, Xiuping Chen, Ying Wang
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2414-2422
Closed Access | Times Cited: 8
Novel Compounds for Targeted Degradation of BRD9 and Their Use for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 13, Iss. 1, pp. 17-18
Open Access | Times Cited: 5
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021) Vol. 13, Iss. 1, pp. 17-18
Open Access | Times Cited: 5
Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network
Gabriel Ichim, Benjamin Gibert, Sahil Adriouch, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 901-901
Open Access | Times Cited: 3
Gabriel Ichim, Benjamin Gibert, Sahil Adriouch, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 901-901
Open Access | Times Cited: 3
Selective degradation of multimeric proteins via chemically induced proximity to TRIM21
Panrui Lu, Y. Cheng, Lei Xue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Panrui Lu, Y. Cheng, Lei Xue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access